295 results on '"Shoda, Tetsuo"'
Search Results
2. Harnessing Digital Pathology And Causal Learning To Improve Eosinophilic Esophagitis Dietary Treatment Assignment
3. Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis
4. Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis
5. Eosinophil Involvement Outside the Esophagus in Eosinophilic Esophagitis
6. Common and disparate clinical presentations and mechanisms in different eosinophilic gastrointestinal diseases
7. Persistent esophageal changes after histologic remission in eosinophilic esophagitis
8. One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: A multisite randomized trial
9. Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis
10. Genetic and Molecular Contributors in Eosinophilic Esophagitis
11. Type 2 Immunity and Age Modify Gene Expression of Coronavirus-induced Disease 2019 Receptors in Eosinophilic Gastrointestinal Disorders.
12. Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial
13. Prospective study of an amino acid–based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial
14. Local type 2 immunity in eosinophilic gastritis
15. Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study
16. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial
17. Development and Application of a Functional Human Esophageal Mucosa Explant Platform to Eosinophilic Esophagitis.
18. Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study
19. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell–Fibroblast Crosstalk
20. Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study.
21. Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study
22. Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multisite cohort
23. Differential effects of proton pump inhibitors on the aryl hydrocarbon receptor in esophageal epithelial cells
24. Effects of Proton Pump Inhibitors on Esophageal Remodeling and Fibrosis in Eosinophilic Esophagitis
25. Persistent Esophageal Changes Following Histologic Remission in Eosinophilic Esophagitis.
26. Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis
27. Induction of sustained remission and reversal of pathologic transcriptome achieved with tezepelumab in an adolescent with eosinophilic esophagitis
28. Type 2 Immunity and Age Modify Gene Expression of COVID19 Receptors in Eosinophilic Gastrointestinal Disorders
29. Factors Associated with Development of Food Allergy in Young Children after Liver Transplantation: A Retrospective Analysis of 10 Years' Experience
30. Gene Expression Patterns in Distinct Endoscopic Findings for Eosinophilic Gastritis in Children
31. Platelets constitutively express IL-33 protein and modulate eosinophilic airway inflammation
32. Preconceptional exposure to oral contraceptive pills and the risk of wheeze, asthma and rhinitis in children
33. Recent advances in understanding the roles of vascular endothelial cells in allergic inflammation
34. Molecular and cellular determinants associated with clinical parameters of eosinophilic gastritis
35. Comparison of gene expression profiles in eosinophilic esophagitis (EoE) between Japan and Western countries
36. Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort
37. Molecular analysis of duodenal eosinophilia
38. Strong association of mast cells with eosinophilic esophagitis‐specific signatures
39. Epithelial cell‐expressed type II IL ‐4 receptor mediates eosinophilic esophagitis
40. Vitamin D receptor and STAT6 interactome governs oesophageal epithelial barrier responses to IL-13 signalling
41. Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission
42. The mast cell pain connection in eosinophilic esophagitis
43. Molecular analysis of duodenal eosinophilia.
44. Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study
45. Esophageal Mast cells in Eosinophilic Esophagitis Are Heterogeneous, Dynamically Activated and Locally Proliferate
46. Esophageal mucosal transcriptional alterations persist in eosinophilic esophagitis patients during remission
47. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell–Fibroblast Crosstalk
48. Diagnostic merits of the Eosinophilic Esophagitis Diagnostic Panel from a single esophageal biopsy
49. A connection found between mast cells and pain in eosinophilic esophagitis
50. Strong association of mast cells with eosinophilic esophagitis‐specific signatures.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.